Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Poseida Therapeutics
Poseida Therapeutics develops targeted cell therapy founded in 2014 by Eric Ostertag.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 16 Feb, 2024
"prospector:3742:3907135"
Amy Sar
edited on 16 Feb, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Immunotherapy
Edits on 15 Feb, 2024
Amy Sar
edited on 15 Feb, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
CAR T-Cell therapy
"prospector:3734:3905696"
Amy Sar
edited on 15 Feb, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
T cell
Edits on 9 Feb, 2024
"NL fact extraction"
Golden Au
edited on 9 Feb, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Genetic engineering
0
Edits on 30 Jan, 2024
"prospector:3668:3885040"
Amy Sar
edited on 30 Jan, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Allogeneic cell therapy
Edits on 1 Dec, 2023
"NL fact extraction"
Golden Au
edited on 1 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
B2X
B2B
0
Edits on 18 Oct, 2023
"Clean up website values by canonicalizing and removing duplicates"
Golden AI
edited on 18 Oct, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
http://www.poseida.com/
Edits on 11 Jul, 2023
"prospector:2957:3536395"
Amy Sar
edited on 11 Jul, 2023
Edits made to:
Infobox
(
+2
properties)
Infobox
Industry
Tissue engineering
Official Website
http://www.poseida.com/
Edits on 24 May, 2023
"Clean up website values by canonicalizing and removing duplicates"
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox
(
+1
/
-2
properties)
Infobox
Official Website
http://www.poseida.com/
https://poseida.com/
Official Website
https://poseida.com
Edits on 22 May, 2023
"prospector:2765:3133617"
Amy Sar
edited on 22 May, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Official Website
http://www.poseida.com/
Edits on 17 May, 2023
"prospector:2755:3130708"
Katrina-Kay Pettitt
edited on 17 May, 2023
Edits made to:
Infobox
(
+3
properties)
Infobox
Industry
Genomics
Genome editing
Technologies Used
CRISPR
Edits on 6 May, 2023
"Covert AngelList URL to Wellfound ID"
Golden AI
edited on 6 May, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Wellfound ID
poseida-therapeutics
Edits on 5 Apr, 2023
"prospector:2583:2634013"
Katrina-Kay Pettitt
edited on 5 Apr, 2023
Edits made to:
Infobox
(
+2
properties)
Infobox
Industry
Healthcare
Regenerative medicine
Edits on 17 Mar, 2023
"prospector:2473:2566798"
Katrina-Kay Pettitt
edited on 17 Mar, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Biotechnology
"prospector:2472:2551818"
Katrina-Kay Pettitt
edited on 16 Mar, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Biology
Edits on 16 Mar, 2023
"prospector:2471:2536116"
Katrina-Kay Pettitt
edited on 16 Mar, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Synthetic biology
Edits on 7 Mar, 2023
"rollback to version 48691558"
Megan Gustafson
edited on 7 Mar, 2023
Infobox
Industry
Cell therapy
0
Edits on 23 Feb, 2023
"prospector:2317:2488175"
Katrina-Kay Pettitt
edited on 23 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Industry
Technology
Edits on 20 Nov, 2022
"update inverses"
Golden AI
edited on 20 Nov, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Investors
Tavistock Life Sciences
0
Edits on 20 Oct, 2022
Alexander Baychikov
edited on 20 Oct, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Number of Employees (Ranges)
250 – 499
0
Number of Employees
290
0
Load more
Find more companies like Poseida Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE